EP3543325A1 - Organic disinfecting agent - Google Patents

Organic disinfecting agent Download PDF

Info

Publication number
EP3543325A1
EP3543325A1 EP18162645.8A EP18162645A EP3543325A1 EP 3543325 A1 EP3543325 A1 EP 3543325A1 EP 18162645 A EP18162645 A EP 18162645A EP 3543325 A1 EP3543325 A1 EP 3543325A1
Authority
EP
European Patent Office
Prior art keywords
amino acid
disinfecting agent
agent
polyglucosamine
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18162645.8A
Other languages
German (de)
French (fr)
Inventor
Sanjeev SWAMY
Rene Dr. GÄlli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Livinguard AG
Original Assignee
Green Impact Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Impact Holding AG filed Critical Green Impact Holding AG
Priority to EP18162645.8A priority Critical patent/EP3543325A1/en
Priority to PCT/EP2019/056880 priority patent/WO2019180041A1/en
Publication of EP3543325A1 publication Critical patent/EP3543325A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/222Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • C11D3/227Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin with nitrogen-containing groups
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/28Heterocyclic compounds containing nitrogen in the ring
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/33Amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10Objects to be cleaned
    • C11D2111/12Soft surfaces, e.g. textile
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10Objects to be cleaned
    • C11D2111/14Hard surfaces

Definitions

  • the present invention relates to an organic disinfecting agent comprising at least one amino acid, at least one amino acid derivative and/or at least one iminosugar, and polyglucosamine.
  • the disinfecting agent can be used for sanitizing surfaces or can be applied in combination with cleaning agents, such as detergents.
  • Disinfectants are extensively used in everyday life to prevent microbial spread and microbial infections, such as in the health care sector, the food industry, agriculture, or in common household products.
  • disinfectants are provided in solution and applied directly onto contaminated surfaces, such as in hospitals or of laboratory equipment, or skin wounds. In case these disinfectants are not neutralized, such as by autoclaving, or cannot be easily neutralized, they finally accumulate in the waste water. Such contamination may ultimately result in the emergence of microbial strains that are resistant to commonly used antimicrobial agents.
  • an antimicrobial agent which comprises environmentally friendly chemical agents.
  • the agents are preferably natural, organic compounds. Such compounds are usually biodegradable, thereby reducing the risk of accumulation and contamination of the environment.
  • the agents should be well tolerated by living tissues and could be used, for example, for sensitive applications such as preservative for food, as wound sanitizing agent or in combination with cleaning agents, for example detergents used in laundry machines.
  • the production of such antimicrobial agents should be cost-efficient, in particular in terms of the costs for the chemical agents used.
  • the present invention solves the shortcomings of the state of the art by providing in a 1 st embodiment of the invention a disinfecting agent comprising
  • the inventors have found that common amino acids, peptides and quaternary ammonium comprising amino acid derivatives, or iminosugars can be combined with polyglucosamine (chitosan) to achieve a high antimicrobial activity.
  • the at least one amino acid, amino acid derivative, iminosugar and/or polyglucosamine each carries at least one positive charge. Such positive charges are believed to adhere to the negatively charged membranes of microorganisms and to disrupt the membrane integrity, thereby acting biocidal.
  • At most 1%, preferably at most 0.8%, more preferably at most 0.1% of the amine groups of polyglucosamine are functionalized with the at least one amino acid, and/or amino acid derivative.
  • the polyglucosamine is non-animal derived.
  • non-animal derived polyglucosamine can be isolated from fungi, such as mucorales.
  • the at least one amino acid is selected from the group consisting of natural amino acid, unnatural amino acid, non-proteinogenic amino acid, and/or wherein the at least one amino acid derivative is selected from the group consisting of peptide and quaternary ammonium comprising amino acid derivative.
  • the amino acid and/or amino acid derivative has an isoelectric point equal to or above 7, preferably equal to or above 8, more preferably equal to or above 8.5, and/or has a pH-independent positive charge.
  • amino acids and/or amino acid derivatives with an isoelectric point above 7 allows that the acids and/or amino acid derivatives carry a positive net charge at any pH value below the isoelectric point. Thus, the higher the isoelectric point, the larger is the range of pH values suitable for providing a positive net charge.
  • amino acids or amino acid derivatives such as quaternary ammonium comprising amino acid derivatives, may have a constant positive charge, which is pH independent. It has been found that a positive charge of the amino acid and/or amino acid derivative applied to the textile enhances the overall antimicrobial activity, in particular against gram-positive and gram-negative bacteria. Positive charges are believed to adhere to the negatively charged membranes of microorganisms and to disrupt the membrane integrity, thereby acting biocidal.
  • the natural, unnatural or non-proteinogenic amino acid is in L configuration, and/or wherein the peptide is an L-peptide.
  • the L-enantiomers of amino acids and peptides can be easily obtained from cultures, e.g. of E. coli, L. lactis or S. cerevisiae, rendering a complicated, cost-inefficient chemical synthesis unnecessary.
  • the amino acid is lysine, arginine, or histidine, preferably arginine.
  • the naturally occurring amino acids lysine, arginine, or histidine, in particular the L-enantiomers thereof, are environmentally friendly, as they can be obtained from common biological cultures. Moreover, these amino acids can be used as food additives or preservatives in the food industry, as they are non-toxic to living tissues. Arginine is one of the preferred amino acids because it is available at comparatively low costs.
  • the peptide is a dipeptide or a polypeptide, preferably wherein the polypeptide contains 3 to 50 amino acids.
  • the amino acid derivative is a lantibiotic, preferably wherein the amino acid derivative is nisin.
  • Nisin is commonly used as a food preservative, and, thus, can be also used for sanitizing packages or other products in the food industry.
  • the iminosugar is D-fagomine.
  • the amino acid derivative is carnitine or betaine.
  • Carnitine in particular L-carnitine
  • betaine are naturally occurring amino acid derivatives, which comprise quaternary ammonium groups that are positively charged in a pH-independent manner.
  • carnitine has proven to have an adequate antimicrobial activity in combination with polyglucosamine.
  • the disinfecting agent comprises arginine and carnitine.
  • arginine and carnitine confers a particularly high antimicrobial activity, e.g. against both gram-negative and gram-positive bacteria.
  • polyglucosamine is essentially free of thiol groups.
  • Essentially free of certain groups or compounds in the context of the present invention means that the respective groups or compounds are comprised only as usual impurities, i.e. they are not added to the formulations of the present invention and/or the formulations of the present invention are not derivatized with the groups.
  • the disinfecting agent comprises at most 1.8%, preferably at most 1%, more preferably at most 0.5% of trehalose, most preferably at most 0.1% trehalose. In a most preferred embodiment, the disinfecting agent is essentially free of trehalose.
  • the disinfecting agent is a solution or suspension.
  • the disinfecting agent of any one of the preceding embodiments comprises at most 10%, preferably at most 5%, more preferably at most 2%, more preferably at most 1%, most preferably at most 0.5% of an organic solvent, based on the total amount of solvent.
  • the organic solvents ethanol or isopropanol can be comprised in very low amounts, or the disinfecting solution can be essentially free of organic solvents, such as ethanol or isopropanol. Thereby, the disinfecting solution can be well tolerated during use, e.g. for cleaning the human skin.
  • the disinfecting agent comprises water as a solvent.
  • the water is the main solvent of the disinfecting agent.
  • the disinfecting agent can be prepared using mainly water as solvent, i.e. more than 50% of the solvent can be water. Preferably water is the only solvent in the disinfecting agent.
  • the disinfecting agent has a pH between pH 4 and pH 12, more preferably to between pH 6 and pH 11.5, even further preferably between pH 8 and pH 11, most preferably between pH 9 and pH 10.5.
  • a basic pH of the disinfecting agent improves the overall antimicrobial activity.
  • the disinfecting agent is in particular effective in its antimicrobial activity when the pH is adjusted to the indicated pH range and in particular to the indicated basic pH range.
  • the disinfecting agent is a powder.
  • the disinfecting agent comprises at most 10%, preferably at most 5%, more preferably at most 2%, further preferably at most 1%, most preferably at most 0.5% of a lyophilisate of polyglucosamine, based on the total weight of chitosan comprised in the disinfection agent.
  • the disinfecting agent is essentially free of a lyophilisate of polyglucosamine.
  • the polyglucosamine is provided in water-soluble form.
  • a water-soluble form of polyglucosamine can be provided by dissolving a powder or flakes comprising polyglucosamine in an acidic medium. By using a water-soluble form in the liquor, polyglucosamine can be well dispersed.
  • the mass ratio between the amino acid or the amino acid derivative and polyglucosamine is between 0.25:1 and 5:1, preferably between 0.5:1 and 3:1, more preferably between 1:1 and 2:1.
  • the mass ratio between the amino acid and of the amino acid derivative together and polyglucosamine is between 2:1 and 5:1, preferably between 3:1 and 4:1.
  • the disinfecting agent further comprises one, two, three, or all four antimicrobial agents selected from the group consisting of propiconazole, silver ions, polyhexamethylene biguanide, quaternary ammonium organosilane.
  • antimicrobial agents are not biodegradable. In certain applications it may nevertheless be desirable to add them because they increase the overall antimicrobial activity of the disinfecting agent.
  • the inventors found that these antimicrobial agents can be well combined with amino acids and/or amino acid derivatives, and polyglucosamine.
  • quaternary ammonium organosilane is a hydrophilic quaternary ammonium organosilane, preferably an organomethoxysilane compound, more preferably N-trimethoxysilylpropyl-n,n,n-trimethylammonium chloride.
  • the disinfecting agent comprises at least one organic acid, preferably selected from the group consisting of acetic acid, citric acid, lactic acid, formic acid and p-toluenesulfonic acid.
  • These acids can improve the solubility of polyglucosamine in the disinfecting agent.
  • At least 90%, preferably at least 95%, more preferably at least 98%, even more preferably at least 99%, further preferably at most 99.9%, and most preferably about 100% of the disinfecting agent is made from a renewable raw material, and/or is biodegradable and/or natural and organic.
  • the present invention is directed to a cleaning agent, such as a detergent, dish-washing detergent, or rinsing agent, comprising the agent of any one of the 1 st to 28 th embodiment.
  • a cleaning agent such as a detergent, dish-washing detergent, or rinsing agent
  • the cleaning agent comprises linear alkyl benzene sulphonate, linear alkyl benzene, a non-ionic tenside and/or an anionic tenside.
  • the cleaning agent comprises soap, glycerine, fats, and other components generally added to soaps.
  • the present invention is directed to a method for the preparation of a disinfecting agent according to any one of embodiments 1 to 28, comprising mixing the at least one amino acid, the at least one amino acid derivative and/or the at least one iminosugar in powder or liquid form and polyglucosamine in powder or liquid form.
  • the 32 nd embodiment at most 3%, preferably at most 2%, more preferably at most 1%, most preferably at most 0.5% of the at least one amino acid, amino acid derivative and/or polyglucosamine are activated with a cross-linking reagent, in particular with a carbodiimide and/or a N-hydroxysuccinimide.
  • the amino acid, amino acid derivative and/or polyglucosamine are essentially free of a crosslinking reagent, in particular with a carbodiimide and/or a N-hydroxysuccinimide.
  • the at least one amino acid, amino acid derivative and/or imino sugar and polyglucosamine are mixed in a solvent, preferably water, to form a solution or suspension, preferably wherein the pH of the solution of suspension is adjusted to between pH 4 and pH 12, more preferably to between pH 6 and pH 11.5, even further preferably between pH 8 and pH 11, most preferably between pH 9 and pH 10.5.
  • the solution or suspension is stirred for at least 10 minutes, preferably at least 20 minutes, more preferably at least 30 minutes, at a temperature of at least 30 °C, preferably at least 40 °C, more preferably at least 50°C, and/or at a temperature of at most 70 °C, preferably at most 60 °C, more preferably at most 55°C.
  • the stirring/incubation step allows for a further increase in antimicrobial activity.
  • the inventors believe that during incubation, polyglucosamine molecules react with the amino acid and/or amino acid derivate, such that an ester bond is formed.
  • a temperature of the reaction mixture of at least 30 °C, more preferably at least 40 °C, even more preferably at least 50 °C, was found to foster the reaction in the incubation step.
  • the present invention is directed to a method for the reduction of microbial contamination in a liquid, comprising applying to the liquid the disinfecting agent according to any one of embodiments 1 to 28 or the cleaning agent according to any one of embodiments 29 to 31.
  • the disinfecting agent or the cleaning agent is added into a washing machine in the course of a laundry cycle for washing one or more textile products.
  • the disinfecting agent or the cleaning agent is added together with a washing detergent into the washing machine, preferably wherein the disinfecting solution is comprised in the washing detergent.
  • the disinfecting agent or the cleaning agent is added into the washing machine at a rinsing step, such that the disinfecting solution remains partially adhered to the one or more textile products at the end of the laundry cycle.
  • the disinfecting agent or the cleaning agent is applied to the liquid, such that the liquid comprises 0.001 to 1% by weight, preferably 0.002 to 0.5% by weight polyglucosamine, 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid, 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid derivative, and/or 0.001 to 1% by weight, preferably 0.002 to 0.5% by weight the iminosugar.
  • the reduction of antimicrobial contamination in the liquid is at least 90%, preferably at least 99%, more preferably at least 99.9%, most preferably at least 99.99%, when measured in accordance with the ASTME-2149 test method against P. aeruginosa, Staphylococcus aureus and/or E. coli.
  • the present invention is directed to a method of sanitizing a surface, in particular a surface contaminated with microbes, comprising applying to the surface a disinfecting agent according to any one of embodiments 1 to 28 or a cleaning agent according to any one of embodiments 29 to 31.
  • the disinfecting agent or cleaning agent is applied to the surface in the course of cleaning the surface, in particular by wiping, rinsing, or mopping and/or with the help of a wipe, towel, or mop.
  • the surface is living human or animal skin, preferably skin of the human hand or face, or the surface is a floor, a kitchen top, a table, a medical device, furniture, in particular in an operating theater or emergency room, a door handle, a dish, cutlery, a steering wheel, a keyboard, bathroom surface, vehicle surface, a surface in a restaurant or hotel, a wall, or an electrical consumer product.
  • the disinfecting agent is applied such that 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight polyglucosamine, 0.0002 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid, 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid derivative, and/or 0.001 to 1% by weight, preferably 0.002 to 0.5% by weight the iminosugar are applied to the surface.
  • the reduction of antimicrobial contamination on the surface is at least 90%, preferably at least 99%, more preferably at least 99.9%, when measured in accordance with the ASTME-2149 test method against P. aeruginosa, Staphylococcus aureus and/or E. coli.
  • antimicrobial as used in the context of the present invention relates to the ability to kill at least some types of microorganisms, or to inhibit the growth or reproduction of at least some types of microorganisms. Said term relates to any compound, agent, product or process that is harmful to one or more "microorganism” as used in the context of the present invention. Preferably, the one or more "microorganism” gets killed by the "antimicrobial" product or process.
  • antimicrobial agent means any chemical compound that acts antimicrobial against at least some types of microorganisms.
  • antimicrobial agents are chitosan, quaternary ammonium organosilane, silver cations, polyhexamethylene biguanide (PHMB), propiconazole, amino acids, amino acid derivatives, and iminosugars.
  • microorganism and “microbe”, which are used interchangeably in the context of the present invention, are defined to comprise any organism too small to be seen by the unaided eye, such as, especially, single-celled organisms.
  • microorganism and “microbe” cover prokaryotes including bacteria and archaea, eukaryotes including protists, animals like dust mites or spider mites, fungi, and plants like green algae, as well as viruses.
  • biodegradable refers to any form of textile, amino acid, amino acid derivative, chitosan, antimicrobial agent or other chemical compounds, which can be decomposed by living cells, such as bacteria.
  • natural and organic refers to organic compounds that may by produced by living organisms. For example, all amino acids that are synthesized by biological cells or chitosan are natural and organic compounds.
  • the present invention relates to a natural and organic disinfecting agent.
  • the agent comprises naturally occurring functional agents, such as amino acids or peptides, in combination with chitosan.
  • the disinfecting agent is environmentally friendly, as the antimicrobial agents, such as natural amino acids, are biodegradable. Moreover, the use of amino acids and/or amino acid derivatives as antimicrobial agents lowers the production costs for the production of the antimicrobial agent, e.g. in comparison to antimicrobial agents comprising chitosan only.
  • the antimicrobial agent comprises at least one amino acid, amino acid derivative and/or iminosugar, and chitosan.
  • Both the amino acid and the amino acid derivative contain at least two functional groups, one of them being a carboxy group, and the other one being an amine group or quaternary amine group. Unless otherwise indicated, the carboxy group and the amino group are not derivatized, e.g. with crosslinking agents.
  • the amino acid may be an alpha-amino acid, as represented by the following structural formula:
  • the amino acid may be a beta-, gamma- or delta-amino acid.
  • the exemplary proteinogenic amino acid L-arginine is represented by the following structural formula:
  • the exemplary non-proteinogenic amino acid derivative L-carnitine is represented by the following structural formula:
  • Chitosan has a structure as shown hereinafter, wherein n indicates the number of monomer units as known in the art:
  • Nisin is a lantibiotic with the following structure:
  • D-fagomine is a iminosugar with the following structure:
  • R'-COOH groups of amino acids and/or amino acid derivatives may react with R"-OH groups of chitosan by forming an ester bond R'-COO-R'.
  • Antimicrobial performance of disinfecting agents according to the invention were performed following the ASTME-2149 test method.
  • test bacteria E. coli, S. aureus, P. aeruginosa
  • the buffer further comprised a detergent as indicated.
  • 5 ⁇ l to 2.5 ml of the antimicrobial agent were added to obtain the total test volume, and the flasks were shaken for 1 hour.
  • 0.3% bovine serum albumin (BSA) was added to the flasks, as indicated in the examples. After incubation, the log reduction over the initial time point was determined.
  • BSA bovine serum albumin
  • the Log Reduction (R) of bacteria was calculated by:
  • Propiconazole is known in the art and commercially available, e.g. Utconazol (manufactured by Utpan Chempro). Propiconazole can be bound to the textile material using a crosslinking agent, in particular a preferably blocked isocyanate compound, which results in urethane bonds, or an acrylate based-product. When using propiconazole, it is preferred to use a crosslinking agent in the liquor, in particular the exhaust liquor. It is even more preferred that the formulation of propiconazole contains the cross linking agent or the cross-linking agent is part of the propiconazole formulation. In the following examples, propiconazol (Utpan Chempro) was provided as a 25% stock solution.
  • the quaternary ammonium organosilane can comprise an organomethoxysilane, preferably N-trimethoxysilylpropyl-N,N,N-trimethylammonium chloride, as provided by Gelest Inc. as a 50% stock solution.
  • Polyhexamethylene biguanide is known in the art and commercially available. In the following examples, polyhexamethylene biguanide (PHMB, Thor GmbH) was provided as a 20% stock solution.
  • PHMB polyhexamethylene biguanide
  • An antimicrobial agent can comprise silver cations.
  • the silver cations are trapped in an inorganic or organic matrix.
  • the inorganic matrix is an aluminosilicate.
  • the organic matrix is a polymeric matrix.
  • Such silver-containing microbial agents are known in the art and available on the market. In the following examples, Silvadur 930 Flex (0.1% silver cations trapped in a polymeric matrix) was provided by Dow Chemical Company.
  • blocked polyisocyanate e.g. oxime-blocked polyisocyanate
  • Oxime-blocked polyisocyanate is, for example, provided by Schoeller Technologies AG.
  • a disinfecting agent according to the invention was prepared by mixing
  • the disinfecting agent was added to 51 ml cell culture in PBS and tested according to ASTME-2149, as described above, with test parameters as compiled in Table 1.
  • Table 1 Antimicrobial performance of different concentrations of the disinfecting agent Sample ID neg. control 0.01% 0.05% 0.10% 0.5% 1% 2% 3% 4% 5% Volume of disinfecting agent 0 5 ⁇ L 25 ⁇ L 50 ⁇ L 250 ⁇ L 0.5 ml 1 ml 1.5 ml 2 ml 2.5 ml Total test volume 51 ml 51.005 ml 51.025 ml 51.05 ml 51.25 ml 51.5 ml 52 ml 52.5 ml 53 ml 53.5 ml Concentration of disinfecting agent in total test volume 0% 0.01% 0.05% 0.10% 0.5% 1% 2% 3% 4% 5% Detergent Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X
  • concentrations of the antimicrobial agent of at least 0.5% confer high antimicrobial activity of at least log 4, i.e. > 99.99% bacterial reduction.
  • concentrations of the disinfecting agent in a concentration of between 0.5% and 1% is also of economic interest, as the costs for the production and application are reasonable.
  • the disinfecting agent can be combined with a nonionic detergent, such as Triton X-100 (Octoxynol 9), e.g. in a cleaning agent.
  • a nonionic detergent such as Triton X-100 (Octoxynol 9)
  • a disinfecting agent according to the invention was prepared by mixing
  • the disinfecting agents 1 to 7 applied in a concentration of about 0.5% have a particularly high antimicrobial activity of more than log 5 (>99.999 reduction) against the gram-positive bacterium S. aureus, even in combination with the anionic washing detergent Surf Excel. Also, the antimicrobial activity of the disinfecting agent was tested with respect to the pH of the disinfecting agent. The ASTME 2149 test was conducted as described in the following table 4.
  • the antimicrobial performance was increased, in particular against E. coli, if the pH of the disinfecting agent was basic, cf. Sample ID 8.
  • the improved activity of the disinfecting agent at basic pH values even outcompetes a increases concentration of the disinfecting agent at a lower pH value.
  • the disinfecting agents 1 to 7 confer a high protection against gram-positive and gram-negative bacteria.
  • a disinfecting agent according to the invention was prepared by mixing
  • the antimicrobial agents were also tested according to the ASTME 2149 test method as described above, using Triton X-100 in the test flasks, as summarized in Table 7.
  • Table 7 Antimicrobial performance of samples 9 and 10 in non-ionic detergent Sample ID 9 10 Volume of antimicrobial agent 0.5 ml 0.5 ml Total Liquid 101.5 ml 101.5 ml Concentration of disinfecting agent in total test volume 0.5% 0.5% Detergent Triton X-100 (0.06%) Triton X-100 (0.06%) Log reduction (ASTME 2149) E.coli 6.02 1.78 S.aureus 5.34 3.14
  • the improved activity of the disinfecting agent at basic pH values was confirmed also when used in combination with the nonionic detergent Triton X-100.
  • the disinfecting agent of Sample ID 9 of table 6 at a pH of 10.44 was compared to the same agent but at a pH of 4.87 (Sample ID 10).
  • the activity of the disinfecting agent at a pH 10.44 increased for E. coli from log 1.78 to 6.02 and for S. aureus still from 3.14 to 5.34.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A disinfecting agent comprising
- at least one amino acid and/or at least one iminosugar or a salt thereof, and
- polyglucosamine or a salt thereof,
wherein the mass ratio between the amino acid and polyglucosamine is 0.25:1-5:1 and wherein at most 1% of the amine groups of polyglucosamine are functionalized with the amino acid.

A cleaning agent, detergent, dish-washing detergent, or rinsing agent, comprising the disinfecting agent.
A method for the preparation of a disinfecting agent, comprising mixing the amino acid and/or the iminosugar in powder or liquid form and polyglucosamine in powder or liquid form, wherein at most 3% of the amino acid and/or polyglucosamine are activated with a cross-linking reagent.
A method for the reduction of microbial contamination in a liquid.
A method of sanitizing a surface.

Description

    Field of the invention
  • The present invention relates to an organic disinfecting agent comprising at least one amino acid, at least one amino acid derivative and/or at least one iminosugar, and polyglucosamine. The disinfecting agent can be used for sanitizing surfaces or can be applied in combination with cleaning agents, such as detergents.
  • Background of the invention
  • Disinfectants are extensively used in everyday life to prevent microbial spread and microbial infections, such as in the health care sector, the food industry, agriculture, or in common household products.
  • However, one major problem arising from the extensive use of disinfectants is the continuous contamination of the environment with these disinfectants. Usually, disinfectants are provided in solution and applied directly onto contaminated surfaces, such as in hospitals or of laboratory equipment, or skin wounds. In case these disinfectants are not neutralized, such as by autoclaving, or cannot be easily neutralized, they finally accumulate in the waste water. Such contamination may ultimately result in the emergence of microbial strains that are resistant to commonly used antimicrobial agents.
  • Therefore, there is a need for an antimicrobial agent, which comprises environmentally friendly chemical agents. The agents are preferably natural, organic compounds. Such compounds are usually biodegradable, thereby reducing the risk of accumulation and contamination of the environment. The agents should be well tolerated by living tissues and could be used, for example, for sensitive applications such as preservative for food, as wound sanitizing agent or in combination with cleaning agents, for example detergents used in laundry machines. Moreover, the production of such antimicrobial agents should be cost-efficient, in particular in terms of the costs for the chemical agents used.
  • Brief description of the invention
  • The present invention solves the shortcomings of the state of the art by providing in a 1st embodiment of the invention a disinfecting agent comprising
    • at least one amino acid, at least one amino acid derivative, and/or at least one iminosugar, and
    • polyglucosamine.
  • The inventors have found that common amino acids, peptides and quaternary ammonium comprising amino acid derivatives, or iminosugars can be combined with polyglucosamine (chitosan) to achieve a high antimicrobial activity. The at least one amino acid, amino acid derivative, iminosugar and/or polyglucosamine each carries at least one positive charge. Such positive charges are believed to adhere to the negatively charged membranes of microorganisms and to disrupt the membrane integrity, thereby acting biocidal.
  • According to a 2nd embodiment, in the 1st embodiment, at most 1%, preferably at most 0.8%, more preferably at most 0.1% of the amine groups of polyglucosamine are functionalized with the at least one amino acid, and/or amino acid derivative.
  • It was found that a complicated coupling of the amino acids or amino acid derivatives to polyglucosamine in terms of a peptide bond between the carboxy groups of the amino acids or amino acid derivatives and the amine groups of polyglucosamine is not required to achieve a high antimicrobial activity. Rather, the compounds may be simply combined in the antimicrobial agent without performing a crosslinking or condensation reaction. Further, it was found that an ester bond between the hydroxy groups of chitosan and carboxy groups of the amino acids and or amino acid derivates can be formed in an acidic solution, which allows that the amine groups of polyglucosamine, the amine groups of the amino acids and/or amino acid and potential further functional groups are non-functionalized and can carry positive charges, e.g. in a solution of neutral pH.
  • According to a 3rd embodiment, in any one of the preceding embodiments, the polyglucosamine is non-animal derived.
  • For example, non-animal derived polyglucosamine can be isolated from fungi, such as mucorales.
  • According to a 4th embodiment, in any one of the 1st to 3rd embodiment, the at least one amino acid is selected from the group consisting of natural amino acid, unnatural amino acid, non-proteinogenic amino acid, and/or wherein the at least one amino acid derivative is selected from the group consisting of peptide and quaternary ammonium comprising amino acid derivative.
  • According to a 5th embodiment, in any one of the 1st to 4th embodiment, the amino acid and/or amino acid derivative has an isoelectric point equal to or above 7, preferably equal to or above 8, more preferably equal to or above 8.5, and/or has a pH-independent positive charge.
  • The use of amino acids and/or amino acid derivatives with an isoelectric point above 7 allows that the acids and/or amino acid derivatives carry a positive net charge at any pH value below the isoelectric point. Thus, the higher the isoelectric point, the larger is the range of pH values suitable for providing a positive net charge. Alternatively or in addition, amino acids or amino acid derivatives, such as quaternary ammonium comprising amino acid derivatives, may have a constant positive charge, which is pH independent. It has been found that a positive charge of the amino acid and/or amino acid derivative applied to the textile enhances the overall antimicrobial activity, in particular against gram-positive and gram-negative bacteria. Positive charges are believed to adhere to the negatively charged membranes of microorganisms and to disrupt the membrane integrity, thereby acting biocidal.
  • According to a 6th embodiment, in any one of preceding embodiments, the natural, unnatural or non-proteinogenic amino acid is in L configuration, and/or wherein the peptide is an L-peptide.
  • The L-enantiomers of amino acids and peptides can be easily obtained from cultures, e.g. of E. coli, L. lactis or S. cerevisiae, rendering a complicated, cost-inefficient chemical synthesis unnecessary.
  • According to a 7th embodiment, in any one of preceding embodiments, the amino acid is lysine, arginine, or histidine, preferably arginine.
  • The naturally occurring amino acids lysine, arginine, or histidine, in particular the L-enantiomers thereof, are environmentally friendly, as they can be obtained from common biological cultures. Moreover, these amino acids can be used as food additives or preservatives in the food industry, as they are non-toxic to living tissues. Arginine is one of the preferred amino acids because it is available at comparatively low costs.
  • According to an 8th embodiment, in any one of preceding embodiments, the peptide is a dipeptide or a polypeptide, preferably wherein the polypeptide contains 3 to 50 amino acids.
  • According to a 9th embodiment, in any one of preceding embodiments, the amino acid derivative is a lantibiotic, preferably wherein the amino acid derivative is nisin.
  • Nisin is commonly used as a food preservative, and, thus, can be also used for sanitizing packages or other products in the food industry.
  • According to a 10th embodiment, in any one of preceding embodiments, the iminosugar is D-fagomine.
  • According to a 11th embodiment, in any one of preceding embodiments, the amino acid derivative is carnitine or betaine.
  • Carnitine (in particular L-carnitine) and betaine are naturally occurring amino acid derivatives, which comprise quaternary ammonium groups that are positively charged in a pH-independent manner. In particular carnitine has proven to have an adequate antimicrobial activity in combination with polyglucosamine.
  • According to a 12th embodiment, in any one of preceding embodiments, the disinfecting agent comprises arginine and carnitine.
  • The combination of arginine and carnitine, in particular L-arginine and L-carnitine, confers a particularly high antimicrobial activity, e.g. against both gram-negative and gram-positive bacteria.
  • According to a 13th embodiment, in any one of preceding embodiments, polyglucosamine is essentially free of thiol groups.
  • "Essentially free" of certain groups or compounds in the context of the present invention means that the respective groups or compounds are comprised only as usual impurities, i.e. they are not added to the formulations of the present invention and/or the formulations of the present invention are not derivatized with the groups.
  • According to a 14th embodiment, in any one of preceding embodiments, the disinfecting agent comprises at most 1.8%, preferably at most 1%, more preferably at most 0.5% of trehalose, most preferably at most 0.1% trehalose. In a most preferred embodiment, the disinfecting agent is essentially free of trehalose.
  • According to a 15th embodiment, in any one of preceding embodiments, the disinfecting agent is a solution or suspension.
  • According to a 16th embodiment, the disinfecting agent of any one of the preceding embodiments comprises at most 10%, preferably at most 5%, more preferably at most 2%, more preferably at most 1%, most preferably at most 0.5% of an organic solvent, based on the total amount of solvent.
  • For example, the organic solvents ethanol or isopropanol can be comprised in very low amounts, or the disinfecting solution can be essentially free of organic solvents, such as ethanol or isopropanol. Thereby, the disinfecting solution can be well tolerated during use, e.g. for cleaning the human skin.
  • According to a 17th embodiment, in any one of preceding embodiments, the disinfecting agent comprises water as a solvent.
  • According to a 18th embodiment, in any one of preceding embodiments, the water is the main solvent of the disinfecting agent.
  • It was found that the disinfecting agent can be prepared using mainly water as solvent, i.e. more than 50% of the solvent can be water. Preferably water is the only solvent in the disinfecting agent.
  • According to a 19th embodiment, in any one of preceding embodiments, the disinfecting agent has a pH between pH 4 and pH 12, more preferably to between pH 6 and pH 11.5, even further preferably between pH 8 and pH 11, most preferably between pH 9 and pH 10.5.
  • It has been found that in particular in combination with anionic tensides, e.g. in a cleaning agent, a basic pH of the disinfecting agent improves the overall antimicrobial activity.
  • The inventors found that the disinfecting agent is in particular effective in its antimicrobial activity when the pH is adjusted to the indicated pH range and in particular to the indicated basic pH range.
  • According to a 20th embodiment, in any one of preceding embodiments 1 to 14, the disinfecting agent is a powder.
  • According to a 21st embodiment, in any one of preceding embodiments, the disinfecting agent comprises at most 10%, preferably at most 5%, more preferably at most 2%, further preferably at most 1%, most preferably at most 0.5% of a lyophilisate of polyglucosamine, based on the total weight of chitosan comprised in the disinfection agent. In a most preferred embodiment, the disinfecting agent is essentially free of a lyophilisate of polyglucosamine.
  • According to a 22nd embodiment, in any one of the preceding embodiments, the polyglucosamine is provided in water-soluble form.
  • A water-soluble form of polyglucosamine can be provided by dissolving a powder or flakes comprising polyglucosamine in an acidic medium. By using a water-soluble form in the liquor, polyglucosamine can be well dispersed.
  • According to a 23rd embodiment, in any one of the preceding embodiments, the mass ratio between the amino acid or the amino acid derivative and polyglucosamine is between 0.25:1 and 5:1, preferably between 0.5:1 and 3:1, more preferably between 1:1 and 2:1.
  • According to a 24th embodiment, in any one of the preceding embodiments, the mass ratio between the amino acid and of the amino acid derivative together and polyglucosamine is between 2:1 and 5:1, preferably between 3:1 and 4:1.
  • According to a 25th embodiment, in any one of the preceding embodiments, the disinfecting agent further comprises one, two, three, or all four antimicrobial agents selected from the group consisting of propiconazole, silver ions, polyhexamethylene biguanide, quaternary ammonium organosilane.
  • These antimicrobial agents are not biodegradable. In certain applications it may nevertheless be desirable to add them because they increase the overall antimicrobial activity of the disinfecting agent. The inventors found that these antimicrobial agents can be well combined with amino acids and/or amino acid derivatives, and polyglucosamine.
  • According to a 26th embodiment, in any one of the preceding embodiments, quaternary ammonium organosilane is a hydrophilic quaternary ammonium organosilane, preferably an organomethoxysilane compound, more preferably N-trimethoxysilylpropyl-n,n,n-trimethylammonium chloride.
  • According to a 27th embodiment, in any one of the preceding embodiments, the disinfecting agent comprises at least one organic acid, preferably selected from the group consisting of acetic acid, citric acid, lactic acid, formic acid and p-toluenesulfonic acid.
  • These acids can improve the solubility of polyglucosamine in the disinfecting agent.
  • According to a 28th embodiment, in any one of the preceding embodiments, at least 90%, preferably at least 95%, more preferably at least 98%, even more preferably at least 99%, further preferably at most 99.9%, and most preferably about 100% of the disinfecting agent is made from a renewable raw material, and/or is biodegradable and/or natural and organic.
  • In a 29th embodiment, the present invention is directed to a cleaning agent, such as a detergent, dish-washing detergent, or rinsing agent, comprising the agent of any one of the 1st to 28th embodiment.
  • According to a 30th embodiment, in the 29th embodiment, the cleaning agent comprises linear alkyl benzene sulphonate, linear alkyl benzene, a non-ionic tenside and/or an anionic tenside.
  • According to a 31st embodiment, in the 29th or 30th embodiment, the cleaning agent comprises soap, glycerine, fats, and other components generally added to soaps.
  • In a 32nd embodiment, the present invention is directed to a method for the preparation of a disinfecting agent according to any one of embodiments 1 to 28, comprising mixing the at least one amino acid, the at least one amino acid derivative and/or the at least one iminosugar in powder or liquid form and polyglucosamine in powder or liquid form.
  • According to a 33rd embodiment, in the 32nd embodiment, at most 3%, preferably at most 2%, more preferably at most 1%, most preferably at most 0.5% of the at least one amino acid, amino acid derivative and/or polyglucosamine are activated with a cross-linking reagent, in particular with a carbodiimide and/or a N-hydroxysuccinimide. In a most preferred embodiment, the amino acid, amino acid derivative and/or polyglucosamine are essentially free of a crosslinking reagent, in particular with a carbodiimide and/or a N-hydroxysuccinimide.
  • According to a 34th embodiment, in the 32nd or 33rd embodiment, the at least one amino acid, amino acid derivative and/or imino sugar and polyglucosamine are mixed in a solvent, preferably water, to form a solution or suspension, preferably wherein the pH of the solution of suspension is adjusted to between pH 4 and pH 12, more preferably to between pH 6 and pH 11.5, even further preferably between pH 8 and pH 11, most preferably between pH 9 and pH 10.5.
  • According to a 35th embodiment, in the preceding embodiment, the solution or suspension is stirred for at least 10 minutes, preferably at least 20 minutes, more preferably at least 30 minutes, at a temperature of at least 30 °C, preferably at least 40 °C, more preferably at least 50°C, and/or at a temperature of at most 70 °C, preferably at most 60 °C, more preferably at most 55°C.
  • The stirring/incubation step allows for a further increase in antimicrobial activity. The inventors believe that during incubation, polyglucosamine molecules react with the amino acid and/or amino acid derivate, such that an ester bond is formed. A temperature of the reaction mixture of at least 30 °C, more preferably at least 40 °C, even more preferably at least 50 °C, was found to foster the reaction in the incubation step.
  • In a 36th embodiment, the present invention is directed to a method for the reduction of microbial contamination in a liquid, comprising applying to the liquid the disinfecting agent according to any one of embodiments 1 to 28 or the cleaning agent according to any one of embodiments 29 to 31.
  • According to a 37th embodiment, in the preceding embodiment, the disinfecting agent or the cleaning agent is added into a washing machine in the course of a laundry cycle for washing one or more textile products.
  • According to a 38th embodiment, in the preceding embodiment, the disinfecting agent or the cleaning agent is added together with a washing detergent into the washing machine, preferably wherein the disinfecting solution is comprised in the washing detergent.
  • According to a 39th embodiment, in the preceding 37th embodiment, the disinfecting agent or the cleaning agent is added into the washing machine at a rinsing step, such that the disinfecting solution remains partially adhered to the one or more textile products at the end of the laundry cycle.
  • According to a 40th embodiment, in any one of the 36th to 39th embodiment, the disinfecting agent or the cleaning agent is applied to the liquid, such that the liquid comprises 0.001 to 1% by weight, preferably 0.002 to 0.5% by weight polyglucosamine, 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid, 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid derivative, and/or 0.001 to 1% by weight, preferably 0.002 to 0.5% by weight the iminosugar.
  • According to a 41st embodiment, in any one of the 36th to 40th embodiment, after 1 hour of incubation, preferably after 30 minutes of incubation, more preferably after 10 minutes of incubation, the reduction of antimicrobial contamination in the liquid is at least 90%, preferably at least 99%, more preferably at least 99.9%, most preferably at least 99.99%, when measured in accordance with the ASTME-2149 test method against P. aeruginosa, Staphylococcus aureus and/or E. coli.
  • In a 42nd embodiment, the present invention is directed to a method of sanitizing a surface, in particular a surface contaminated with microbes, comprising applying to the surface a disinfecting agent according to any one of embodiments 1 to 28 or a cleaning agent according to any one of embodiments 29 to 31.
  • According to a 43rd embodiment, in the preceding embodiment, the disinfecting agent or cleaning agent is applied to the surface in the course of cleaning the surface, in particular by wiping, rinsing, or mopping and/or with the help of a wipe, towel, or mop.
  • According to a 44th embodiment, in the preceding embodiment, the surface is living human or animal skin, preferably skin of the human hand or face, or the surface is a floor, a kitchen top, a table, a medical device, furniture, in particular in an operating theater or emergency room, a door handle, a dish, cutlery, a steering wheel, a keyboard, bathroom surface, vehicle surface, a surface in a restaurant or hotel, a wall, or an electrical consumer product.
  • According to a 45th embodiment, in any one of the 42nd to 44th embodiments, the disinfecting agent is applied such that 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight polyglucosamine, 0.0002 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid, 0.001 to 1% by weight, preferably 0.01 to 0.5% by weight the amino acid derivative, and/or 0.001 to 1% by weight, preferably 0.002 to 0.5% by weight the iminosugar are applied to the surface.
  • According to a 46th embodiment, in any one of the 42nd to 45th embodiments, after 1 hour of incubation, preferably after 30 minutes of incubation, more preferably after 10 minutes of incubation, the reduction of antimicrobial contamination on the surface is at least 90%, preferably at least 99%, more preferably at least 99.9%, when measured in accordance with the ASTME-2149 test method against P. aeruginosa, Staphylococcus aureus and/or E. coli.
  • All percentages hereinafter refer to weight unless otherwise indicated. "gpl" or "GPL" stands for "grams per liter". "R.t." or "RT" stands for "room temperature", which is a temperature in the range of 15 to 35 °C.
  • The term "antimicrobial" as used in the context of the present invention relates to the ability to kill at least some types of microorganisms, or to inhibit the growth or reproduction of at least some types of microorganisms. Said term relates to any compound, agent, product or process that is harmful to one or more "microorganism" as used in the context of the present invention. Preferably, the one or more "microorganism" gets killed by the "antimicrobial" product or process.
  • The term "antimicrobial agent" as used herein means any chemical compound that acts antimicrobial against at least some types of microorganisms. Exemplary antimicrobial agents are chitosan, quaternary ammonium organosilane, silver cations, polyhexamethylene biguanide (PHMB), propiconazole, amino acids, amino acid derivatives, and iminosugars.
  • The terms "microorganism" and "microbe", which are used interchangeably in the context of the present invention, are defined to comprise any organism too small to be seen by the unaided eye, such as, especially, single-celled organisms. In particular, the terms "microorganism" and "microbe" cover prokaryotes including bacteria and archaea, eukaryotes including protists, animals like dust mites or spider mites, fungi, and plants like green algae, as well as viruses.
  • The term "biodegradable" as used herein refers to any form of textile, amino acid, amino acid derivative, chitosan, antimicrobial agent or other chemical compounds, which can be decomposed by living cells, such as bacteria.
  • The term "natural and organic" as used herein refers to organic compounds that may by produced by living organisms. For example, all amino acids that are synthesized by biological cells or chitosan are natural and organic compounds.
  • Detailed description of the invention
  • Preferred embodiments and examples of the invention will be described in the following detailed description. It is emphasized, however, that the present invention is not limited to these embodiments.
  • The present invention relates to a natural and organic disinfecting agent. Advantageously, the agent comprises naturally occurring functional agents, such as amino acids or peptides, in combination with chitosan.
  • The disinfecting agent is environmentally friendly, as the antimicrobial agents, such as natural amino acids, are biodegradable. Moreover, the use of amino acids and/or amino acid derivatives as antimicrobial agents lowers the production costs for the production of the antimicrobial agent, e.g. in comparison to antimicrobial agents comprising chitosan only.
  • Functional agents:
  • The antimicrobial agent comprises at least one amino acid, amino acid derivative and/or iminosugar, and chitosan.
  • Both the amino acid and the amino acid derivative contain at least two functional groups, one of them being a carboxy group, and the other one being an amine group or quaternary amine group. Unless otherwise indicated, the carboxy group and the amino group are not derivatized, e.g. with crosslinking agents. The amino acid may be an alpha-amino acid, as represented by the following structural formula:
    Figure imgb0001
  • In other embodiments, the amino acid may be a beta-, gamma- or delta-amino acid.
  • The exemplary proteinogenic amino acid L-arginine is represented by the following structural formula:
    Figure imgb0002
  • The exemplary non-proteinogenic amino acid derivative L-carnitine is represented by the following structural formula:
    Figure imgb0003
  • Chitosan has a structure as shown hereinafter, wherein n indicates the number of monomer units as known in the art:
    Figure imgb0004
  • Nisin is a lantibiotic with the following structure:
    Figure imgb0005
  • D-fagomine is a iminosugar with the following structure:
    Figure imgb0006
  • When the amino acids and/or amino acid derivatives are used in combination with chitosan, under the reaction conditions disclosed herein, R'-COOH groups of amino acids and/or amino acid derivatives may react with R"-OH groups of chitosan by forming an ester bond R'-COO-R'.
  • Examples
  • The invention will be further described by the following examples which illustrate the preparation of disinfection agents, without limiting the invention.
  • ASTME-2149 test method for antimicrobial performance:
  • Antimicrobial performance of disinfecting agents according to the invention were performed following the ASTME-2149 test method.
  • Briefly, the test bacteria (E. coli, S. aureus, P. aeruginosa) were cultured in liquid culture and adjusted to 107 CFU/ml in PBS buffer in cell culture flasks, as specified in the examples (volume: 51 or 101 ml). In some examples, the buffer further comprised a detergent as indicated. To the flasks, 5 µl to 2.5 ml of the antimicrobial agent, as indicated in the examples, were added to obtain the total test volume, and the flasks were shaken for 1 hour. Optionally, 0.3% bovine serum albumin (BSA) was added to the flasks, as indicated in the examples. After incubation, the log reduction over the initial time point was determined.
  • The Log Reduction (R) of bacteria was calculated by:
    • B [log(number bacteria recovered from the inoculated flask immediately after inoculation, i.e. at 0 contact time)] - A [log(number of bacteria recovered from the inoculated flask incubated over the desired contact period (1 hour))].
    Chemicals
  • The following chemicals were or can be used:
    • L-arginine is known in the art and commercially available, e.g. by Sciencelab. In the following examples, L-arginine is provided as a powder with 100% by weight.
    • L-carnitine was provided by Lonza Specialty Chemicals Switzerland as a powder with > 98% by weight.
  • Chitosan (8% solution) was provided by Goyen Chem, Taiwan.
  • Propiconazole is known in the art and commercially available, e.g. Utconazol (manufactured by Utpan Chempro). Propiconazole can be bound to the textile material using a crosslinking agent, in particular a preferably blocked isocyanate compound, which results in urethane bonds, or an acrylate based-product. When using propiconazole, it is preferred to use a crosslinking agent in the liquor, in particular the exhaust liquor. It is even more preferred that the formulation of propiconazole contains the cross linking agent or the cross-linking agent is part of the propiconazole formulation. In the following examples, propiconazol (Utpan Chempro) was provided as a 25% stock solution.
  • The quaternary ammonium organosilane can comprise an organomethoxysilane, preferably N-trimethoxysilylpropyl-N,N,N-trimethylammonium chloride, as provided by Gelest Inc. as a 50% stock solution.
  • Polyhexamethylene biguanide is known in the art and commercially available. In the following examples, polyhexamethylene biguanide (PHMB, Thor GmbH) was provided as a 20% stock solution.
  • An antimicrobial agent can comprise silver cations. In particular embodiments, the silver cations are trapped in an inorganic or organic matrix. Preferably, the inorganic matrix is an aluminosilicate. Preferably, the organic matrix is a polymeric matrix. Such silver-containing microbial agents are known in the art and available on the market. In the following examples, Silvadur 930 Flex (0.1% silver cations trapped in a polymeric matrix) was provided by Dow Chemical Company.
  • As a cross-linker, blocked polyisocyanate, e.g. oxime-blocked polyisocyanate, can be used. Oxime-blocked polyisocyanate is, for example, provided by Schoeller Technologies AG.
  • Example 1
  • A disinfecting agent according to the invention was prepared by mixing
    • 100 gpl chitosan solution (8% stock solution; i.e. 8 gpl chitosan)
    • 35 gpl L-arginine
    • 35 gpl L-carnitine
    in water. The pH of the mixture was 10.1. The mixture was stirred for 10 minutes at room temperature to obtain the disinfecting agent.
  • The disinfecting agent was added to 51 ml cell culture in PBS and tested according to ASTME-2149, as described above, with test parameters as compiled in Table 1. Table 1: Antimicrobial performance of different concentrations of the disinfecting agent
    Sample ID neg. control 0.01% 0.05% 0.10% 0.5% 1% 2% 3% 4% 5%
    Volume of disinfecting agent 0 5 µL 25 µL 50 µL 250 µL 0.5 ml 1 ml 1.5 ml 2 ml 2.5 ml
    Total test volume 51 ml 51.005 ml 51.025 ml 51.05 ml 51.25 ml 51.5 ml 52 ml 52.5 ml 53 ml 53.5 ml
    Concentration of disinfecting agent in total test volume 0% 0.01% 0.05% 0.10% 0.5% 1% 2% 3% 4% 5%
    Detergent Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%) Triton X-100 (0.06%)
    Log reduction (ASTME 2149)
    P. aeruginosa 0.03 0.98 1.56 2.81 4.57 5.24 5.24 5.24 5.24 5.24
    E. coli 0.02 0.93 1.44 2.94 4.67 5.38 5.38 5.38 5.38 5.38
    S. aureus nd nd nd nd nd 5.55 5.85 5.85 5.85 5.85
  • As can be derived from the above table 1, concentrations of the antimicrobial agent of at least 0.5% confer high antimicrobial activity of at least log 4, i.e. > 99.99% bacterial reduction. The use of the disinfecting agent in a concentration of between 0.5% and 1% is also of economic interest, as the costs for the production and application are reasonable.
  • Moreover, the results show that the disinfecting agent can be combined with a nonionic detergent, such as Triton X-100 (Octoxynol 9), e.g. in a cleaning agent.
  • Example 2
  • A disinfecting agent according to the invention was prepared by mixing
    • 100 gpl chitosan solution (8% stock solution; i.e. 8 gpl chitosan)
    • 35 gpl L-arginine and/or 35 gpl L-carnitine
    in water. The pH of the mixture was adjusted, as specified in the following table 2. The mixture was stirred for 10 minutes at room temperature or 50 °C, as indicated below, to obtain the disinfecting agents. Table 2: Preparation of disinfecting agents with varying concentrations and pH values
    Sample ID 1 2 3 4 5 6 7 8
    Chitosan (gpl) 100 100 100 100 100 100 100 100
    L-arginine (gpl) 0 35 35 35 0 0 0 35
    L-carnitine (gpl) 35 35 35 35 35 35 35 35
    pH 5.51 4.58 4.5 4.51 4.51 4.51 4.51 10.1
    pH adjusting chemical - Acetic acid Formic acid Lactic acid Acetic acid Formic acid Lactic acid -
    pH adjusting chemical (gpl) - 22 18 24 2 1.8 2.5 -
    Incubation temperature R.T. 50°C 50°C 50°C 50°C 50°C 50°C R.T.
    Incubation time (stirring) 10 min 10 min 10 min 10 min 10 min 10 min 10 min 10 min
  • Each disinfecting agent was added to 101 ml cell culture in PBS and tested according to the ASTME 2149 test method as described above. The total test volume further comprised 0.3% BSA and 0.15% of the detergent "Surf Excel Quickwash powder". Surf Excel comprises anionic detergents. The test parameters and results are summarized in Table 3. Table 3: Antimicrobial performance of samples 1 to 7 in Surf Excel
    Sample ID 1 2 3 4 5 6 7 Negative control
    Volume of disinfecting agent 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml distilled water
    Total test volume 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml
    Concentration of disinfecting agent in total test volume 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%
    Detergent Surf Excel 0.15% Surf Excel 0.15% Surf Excel 0.15% Surf Excel 0.15% Surf Excel 0.15% Surf Excel 0.15% Surf Excel 0.15% Triton X-100 0.15%
    BSA 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% -
    Log reduction (ASTME 2149)
    E.coli 1.15 1.49 1.5 1.28 1.49 1.78 1.03 0.49
    S.aureus 5.32 5.64 5.4 5.33 5.61 5.9 5.61 nd
  • As can be derived from the above table 3, the disinfecting agents 1 to 7, applied in a concentration of about 0.5%, have a particularly high antimicrobial activity of more than log 5 (>99.999 reduction) against the gram-positive bacterium S. aureus, even in combination with the anionic washing detergent Surf Excel.
    Also, the antimicrobial activity of the disinfecting agent was tested with respect to the pH of the disinfecting agent. The ASTME 2149 test was conducted as described in the following table 4. Table 4: Antimicrobial performance of samples 2 and 8 in Surf Excel
    Sample ID 2 2 8
    Volume of disinfecting agent 1 ml 2 ml 1 ml
    Total test volume 102 ml 103 ml 102 ml
    Concentration of disinfecting agent in total test volume 1% 2% 1%
    Detergent Surf Excel 0.15% Surf Excel 0.15% Surf Excel 0.15%
    BSA 0.3% 0.3% 0.3%
    Log reduction (ASTME 2149)
    E.coli 1.23 1.24 4.8
    S.aureus 4.29 4.42 5.9
    P. aerogunosa 3.4 3.56 4.5
  • As can be derived from table 4, the antimicrobial performance was increased, in particular against E. coli, if the pH of the disinfecting agent was basic, cf. Sample ID 8. The improved activity of the disinfecting agent at basic pH values even outcompetes a increases concentration of the disinfecting agent at a lower pH value.
  • The antimicrobial agents were also tested according to the ASTME 2149 test method as described above, using no detergent in the test flasks, as summarized in Table 5. Table 5: Antimicrobial performance of samples 1 to 7 without detergent
    Sample ID 1 2 3 4 5 6 7 Negative control
    Volume of antimicrobial agent 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml distilled water
    Total Liquid 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml 101.5 ml
    Concentration of disinfecting agent in total test volume 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%
    Detergent - - - - - - - -
    BSA 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% -
    Log reduction (ASTME 2149)
    E.coli 3.61 4.37 4.37 3.76 3.64 3.84 3 0.13
    S.aureus 2.04 2.6 2.67 2.3 2.37 2.38 1.86 -0.05
  • As can be derived from table 5, also in the absence of any detergent, the disinfecting agents 1 to 7 confer a high protection against gram-positive and gram-negative bacteria.
  • Example 3
  • A disinfecting agent according to the invention was prepared by mixing
    • 100 gpl chitosan solution (8% stock solution; i.e. 8 gpl chitosan)
    • 70 gpl L-arginine and 70 gpl L-carnitine
    in water. The pH of the mixture was adjusted, as specified in the following table 6. The mixture was stirred for 10 minutes at room temperature or 50 °C, as indicated below, to obtain the disinfecting agents. Table 6: Preparation of disinfecting agents with varying pH values
    Sample ID 9 10
    Chitosan (gpl) 100 100
    L-arginine (gpl) 70 70
    L-carnitine (gpl) 70 70
    pH 10.44 4.87
    pH adjusting chemical - Acetic acid
    pH adjusting chemical (gpl) - 36
    Incubation temperature R.T. R.T.
    Incubation time (stirring) 10 min 10 min
  • The antimicrobial agents were also tested according to the ASTME 2149 test method as described above, using Triton X-100 in the test flasks, as summarized in Table 7. Table 7: Antimicrobial performance of samples 9 and 10 in non-ionic detergent
    Sample ID 9 10
    Volume of antimicrobial agent 0.5 ml 0.5 ml
    Total Liquid 101.5 ml 101.5 ml
    Concentration of disinfecting agent in total test volume 0.5% 0.5%
    Detergent Triton X-100 (0.06%) Triton X-100 (0.06%)
    Log reduction (ASTME 2149)
    E.coli 6.02 1.78
    S.aureus 5.34 3.14
  • In view of the results shown in table 7, the improved activity of the disinfecting agent at basic pH values was confirmed also when used in combination with the nonionic detergent Triton X-100. Specifically, the disinfecting agent of Sample ID 9 of table 6 at a pH of 10.44 was compared to the same agent but at a pH of 4.87 (Sample ID 10). The activity of the disinfecting agent at a pH 10.44 increased for E. coli from log 1.78 to 6.02 and for S. aureus still from 3.14 to 5.34.

Claims (15)

  1. A disinfecting agent comprising
    - at least one amino acid, at least one amino acid derivative, and/or at least one iminosugar or a salt thereof, and
    - polyglucosamine or a salt thereof,
    wherein the mass ratio between the amino acid or the amino acid derivative and polyglucosamine is between 0.25:1 and 5:1, preferably between 0.5:1 and 3:1, more preferably between 1:1 and 2:1,
    and wherein at most 1%, preferably at most 0.8%, more preferably at most 0.1% of the amine groups of polyglucosamine are functionalized with the at least one amino acid and/or amino acid derivative.
  2. The disinfecting agent of claim 1, wherein the at least one amino acid is selected from the group consisting of natural amino acid, unnatural amino acid, non-proteinogenic amino acid, and/or wherein the at least one amino acid derivative is selected from the group consisting of peptide and quaternary ammonium comprising amino acid derivative.
  3. The disinfecting agent of claim 1 or 2, wherein the amino acid and/or amino acid derivative has an isoelectric point equal to or above 7, preferably equal to or above 8, more preferably equal to or above 8.5, and/or has a pH-independent positive charge.
  4. The disinfecting agent of any one of the preceding claims 1 to 3, wherein the amino acid is lysine, arginine, or histidine, preferably arginine; and/or wherein the amino acid derivative is a lantibiotic, preferably wherein the amino acid derivative is nisin; and/or wherein the iminosugar is D-fagomine.
  5. The disinfecting agent of any one of the preceding claims 1 to 4, wherein the amino acid derivative is carnitine or betaine.
  6. The disinfecting agent of any one of the preceding claims 1 to 5, wherein the disinfecting agent has a pH between pH 4 and pH 12, more preferably to between pH 6 and pH 11.5, even further preferably between pH 8 and pH 11, most preferably between pH 9 and pH 10.5.
  7. The disinfecting agent of any one of the preceding claims 1 to 6, wherein the disinfecting agent is a solution or suspension.
  8. The disinfecting agent of claim 7, comprising water as a solvent.
  9. The disinfecting agent of any one of the preceding claims 1 to 6, wherein the disinfecting agent is a powder.
  10. The disinfecting agent of any one of the preceding claims 1 to 9, wherein the mass ratio between the amino acid and of the amino acid derivative together and polyglucosamine is between 2:1 and 5:1, preferably between 3:1 and 4:1.
  11. The disinfecting agent of any one of the preceding claims 1 to 10, further comprising one, two, three, or all four antimicrobial agents selected from the group consisting of propiconazole, silver ions, polyhexamethylene biguanide, quaternary ammonium organosilane.
  12. A cleaning agent, detergent, dish-washing detergent, or rinsing agent, comprising the disinfecting agent of any one of claims 1 to 11.
  13. A method for the preparation of a disinfecting agent according to any one of claims 1 to 11, comprising mixing the at least one amino acid, the at least one amino acid derivative and/or the at least one iminosugar in powder or liquid form and polyglucosamine in powder or liquid form,
    wherein at most 3%, preferably at most 2%, more preferably at most 1%, most preferably at most 0.5% of the at least one amino acid, amino acid derivative, and/or polyglucosamine are activated with a cross-linking reagent, in particular with a carbodiimide and/or a N-hydroxysuccinimide.
  14. A method for the reduction of microbial contamination in a liquid, comprising applying to the liquid the disinfecting agent according to any one of claims 1 to 11 or the cleaning agent according to claim 12.
  15. A method of sanitizing a surface, in particular a surface contaminated with microbes, comprising applying to the surface a disinfecting agent according to any one of claims 1 to 11 or a cleaning agent according to claim 12.
EP18162645.8A 2018-03-19 2018-03-19 Organic disinfecting agent Withdrawn EP3543325A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP18162645.8A EP3543325A1 (en) 2018-03-19 2018-03-19 Organic disinfecting agent
PCT/EP2019/056880 WO2019180041A1 (en) 2018-03-19 2019-03-19 Organic disinfecting agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18162645.8A EP3543325A1 (en) 2018-03-19 2018-03-19 Organic disinfecting agent

Publications (1)

Publication Number Publication Date
EP3543325A1 true EP3543325A1 (en) 2019-09-25

Family

ID=61691815

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18162645.8A Withdrawn EP3543325A1 (en) 2018-03-19 2018-03-19 Organic disinfecting agent

Country Status (2)

Country Link
EP (1) EP3543325A1 (en)
WO (1) WO2019180041A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230044014A1 (en) * 2021-08-05 2023-02-09 Prerna Goradia Surface disinfectant formulation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013774A1 (en) * 1992-12-09 1994-06-23 Allergan, Inc. Cleaning compositions and method for hydrophilic contact lenses
US6723867B1 (en) * 1999-08-20 2004-04-20 Cognis Deutschland Gmbh & Co. Kg Branched, substantially unsaturated fatty alcohol sulfates
US20150051265A1 (en) * 2012-03-21 2015-02-19 Engene, Inc. Dually Derivatized Chitosan Nanoparticles and Methods of Making and Using the Same
US20180193236A1 (en) * 2015-08-27 2018-07-12 Lg Household & Health Care Ltd. Composition for surface modification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066403A1 (en) * 2011-11-03 2013-05-10 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013774A1 (en) * 1992-12-09 1994-06-23 Allergan, Inc. Cleaning compositions and method for hydrophilic contact lenses
US6723867B1 (en) * 1999-08-20 2004-04-20 Cognis Deutschland Gmbh & Co. Kg Branched, substantially unsaturated fatty alcohol sulfates
US20150051265A1 (en) * 2012-03-21 2015-02-19 Engene, Inc. Dually Derivatized Chitosan Nanoparticles and Methods of Making and Using the Same
US20180193236A1 (en) * 2015-08-27 2018-07-12 Lg Household & Health Care Ltd. Composition for surface modification

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JEON YOU-JIN ET AL: "Effect of antimicrobial activity by chitosan oligosaccharide N-conjugated with asparagine", JOURNAL OF MICROBIOLOGY AND BIOTECHNOL, KOREAN SOCIETY FOR APPLIED MICROBIOLOGY, SEOUL, KR, vol. 11, no. 2, 1 April 2001 (2001-04-01), pages 281 - 286, XP008081226, ISSN: 1017-7825 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230044014A1 (en) * 2021-08-05 2023-02-09 Prerna Goradia Surface disinfectant formulation

Also Published As

Publication number Publication date
WO2019180041A1 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
JP6785789B2 (en) Antimicrobial composition
Fredell Biological properties and applications of cationic surfactants
EP2797413B1 (en) Anti-microbial composition
US8940792B2 (en) Antimicrobial composition and methods for using same
CN1736198A (en) Deep penetrating anti-microbial compositions
US8226993B2 (en) Non-toxic anti microbial composition
EP3500102B1 (en) Anti-microbial composition
Ibrahim et al. Antimicrobial agents for textiles: types, mechanisms and analysis standards
EP3543396B1 (en) Organic antimicrobial textile
US10463042B2 (en) Anti-microbial compositions and related methods
JP6025262B2 (en) Synergistic disinfecting composition comprising essential oil
EP3543325A1 (en) Organic disinfecting agent
Campana et al. Experimental approach for a possible integrated protocol to determine sanitizer activity against both planktonic bacteria and related biofilms
JP5744881B2 (en) Composition of dibromomalonamide and its use as a biocide
US6114396A (en) Sterilizing or disinfecting composition
US20100144877A1 (en) Synergistic Enhancement of Calcium Propionate
Rajitha et al. Assessment of alkylimidazolium chloride ionic liquid formulations for cleaning and disinfection of environmental surfaces
JP2023550769A (en) biocide
CN108728261B (en) Environment-friendly physical bacteriostatic lotion and application thereof
KR20150120656A (en) Composition of non-volative antibacterial agents for fabrics
US20140030304A1 (en) Process for the Treatment of Synthetic Textiles with Cationic Biocides
US11622930B2 (en) Antimicrobial agent
JPH10237320A (en) Antimicrobial resin composition and antimicrobial resin molded product using the same
JP7073436B2 (en) Cleaning composition
WO2004049800A1 (en) Magnetic microbicides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40007459

Country of ref document: HK

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LIVINGUARD AG

RIC1 Information provided on ipc code assigned before grant

Ipc: C11D 3/22 20060101ALI20210820BHEP

Ipc: C11D 3/28 20060101ALI20210820BHEP

Ipc: C11D 3/33 20060101ALI20210820BHEP

Ipc: C11D 3/48 20060101ALI20210820BHEP

Ipc: C11D 11/00 20060101AFI20210820BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20211102

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GAELLI, RENE, DR.

Inventor name: SWAMY, SANJEEV

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220315